Mair Therapeutics Announces Scientific Collaboration with Radboud University to Advance TMEM175 Agonists for Parkinson's Disease

NIJMEGEN, The Netherlands, Jan. 26, 2026 /PRNewswire/ -- Mair Therapeutics, a Dutch biotechnology company pioneering lysosomal-targeted therapies for neurodegenerative diseases, today announced a scientific collaboration with Radboud University to accelerate the discovery of...

Read More